All Aedes articles
-
NewsTraditional dengue alerts are missing the mark as Vietnam’s climate shifts—researchers propose a one health solution
For decades, Vietnam’s dengue surveillance relied on a straightforward logic: when cases exceed the five-year average by a sufficient margin, sound the alarm. That logic is now breaking down.
-
NewsCommentary: Dengue viral infection and associated liver disease
A new commentary highlights the time course of serological and liver enzyme elevations in mild versus severe dengue, emphasizes early recognition of progression to acute liver failure, and reviews current vaccination and prevention strategies.
-
NewsMosquito saliva may hold clues to fighting chikungunya inflammation
Scientists have uncovered a surprising mechanism showing how mosquito saliva can alter the human body’s immune response during chikungunya virus (CHIKV) infection - it not only transmits the virus but also influences how the body’s immune system responds.
-
NewsT cells’ capability to fully prevent acute viral infections opens new avenues for vaccine development
Scientists have discovered that T cells—white blood cells that can destroy harmful pathogens—can completely prevent viral infection, to an extent previously thought only possible due to neutralising antibodies.
-
NewsIndian Ocean surface temperature could help anticipate dengue outbreaks
An international research team has recently identified a global climate indicator that may help improve predictions about the magnitude of dengue outbreaks several months in advance.
-
NewsCases of chikungunya and zika fall in Brazil, but most risk clusters rise
Researchers observed spatial and temporal patterns of occurrence and co-occurrence for the two arboviral diseases in all Brazilian municipalities, alongside the influence of environmental and socio-economic factors.
-
NewsValneva vaccinates first participant in pediatric trial of single-shot Chikungunya vaccine
Valneva SE has announced that the first participant has been vaccinated in the Phase 2 clinical trial evaluating the safety and immunogenicity in children of two different dose levels of Valneva’s single-shot chikungunya vaccine.